Select therapeutic use:
Indications for MIOSTAT:
To obtain miosis during eye surgery. To reduce the intensity of intraocular pressure elevation in the first 24 hours after cataract surgery.
See full labeling. Withdraw contents into a dry sterile syringe and replace the needle with an atraumatic cannula prior to intraocular instillation. Gently instill no more than ½ mL into the anterior chamber; may be instilled before or after securing sutures. Usually within 2–5 mins after application for maximal miosis effects.
For single-dose intraocular use only. Acute cardiac failure. Bronchial asthma. Peptic ulcer. Hyperthyroidism. GI spasm. Urinary tract obstruction. Parkinson's disease. Latex allergy. Pregnancy (Cat.C). Nursing mothers.
Corneal clouding, persistent bullous keratopathy, retinal detachment, postoperative iritis; flushing, sweating, epigastric distress, abdominal cramps, tightness in urinary bladder, headache.
Single-use vial (1.5mL)—12